top of page
Long-time Chief Executive Officer Ben Silbermann of Pinterest would step down, handing over the reins of the social media platform to Google...

Stock Market

Google executive to take over as a new CEO of Pinterest

Top accounting firm Ernst & Young has been slammed with a record $100 million fine from the US government...

Stock Market

Accounting firm gets 100 million fine for faulty regulations

The Indian rupee slipped into a fresh low today and extended losses against the US dollar.


The rupee tumbled to a new low against the dollar in the midst of an increase in crude oil price

Wall Street saw a sharp fall at its closing in a broad sell-off. Consumers' worries over recession have sparked up...

Stock Market

Wall Street Lose Balance after recession strikes growth fear among consumers’

Soaring inflation may be pushing the US economy into a deep recession. Last week's 0.75% interest rate hike by the Federal Reserve...

Stock Market

Inflation ringing the recession bell - Mohammed Shaheen


8 Mar 2022

Moderna Prepares for Future Pandemic through Human Vaccine Trials against 15 Viruses

The Index Today

Moderna Inc. is gearing up to start human trials for vaccines against 15 highly infectious viruses and their pathogens by 2025.

This program has been instituted to develop vaccines against a wide array of contagious viruses in order to avert another potential pandemic in the future. It comes amid recent criticism against Moderna by activists for not supplying vaccine doses to poor countries soon enough.

As per a statement by Moderna, their agenda involves creating archetypal vaccines against viruses responsible for causing the Middle East Respiratory Syndrome, Ebola, Marburg infection, as well as dengue fever and chikungunya.

According to Bloomberg News, the company has already started human vaccine trials against key viruses, namely the Zika and HIV viruses. The development for the vaccine against Nipah is also underway.

In a statement, Moderna’s CEO Stephane Bancel said, “Since our beginning, we have focused on developing a global health vaccine program. Today, we are renewing that focus by expanding our work to develop vaccines against priority pathogens that threaten global health.”  

Clay pottery with table linens
bottom of page